The latest trading session saw McKesson (MCK) ending at $513.67, denoting a +0.86% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 0.76%. Elsewhere, ...

McKesson Corporation was the highest-scoring large cap on the most recent Magic Formula screen for Oct. 2024. Click here to ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” third quarter ...

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

McKesson Co. (NYSE:MCK – Get Free Report) has earned an average recommendation of “Moderate Buy” from the sixteen brokerages ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

McKesson (MCK) closed at $508 in the latest ... the company's expected earnings growth trajectory. The Medical - Dental Supplies industry had an average PEG ratio of 1.92 as trading concluded ...

Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $612.00.